Investments & Finance

The Protein Brewery Secures €30M to Advance Its Proprietary Mycoprotein

The Protein Brewery, a Dutch company producing fungi-based food ingredients, has secured €30 million in Series B funding.

The round saw participation from new investors Invest-NL and the Brabant Development Agency (BOM), alongside existing investors Novo Holdings, Unovis Asset Management, and Madeli. The Protein Brewery will use the capital to advance its proprietary mycoprotein, Fermotein®, and strengthen its commercial presence.

This will include expanding production capacity at the company’s Mijkenbroek facility and developing the Fermotein innovation platform to unlock new nutrition and product application possibilities. The Protein Brewery will work to commercialize Fermotein in the US and Europe, while strengthening sales and application expertise to ensure the ingredient meets the needs of food manufacturers worldwide.

© The Protein Brewery

The company will reportedly launch Fermotein with several customers in the US in the coming months; it is also expanding its business in Singapore, where the mycelium protein received novel food approval last year. Furthermore, The Protein Brewery is preparing for market launch in the EU and the UK, which will follow once regulatory approval is in place.

“Redefining how food is made”

Fermotein is a high-protein, high-fiber ingredient that can reportedly be integrated into a variety of products, including baked goods, snacks, dairy alternatives, protein shakes, functional bars, and meal replacement drinks. The ingredient is said to be tasteless and odorless, and The Protein Brewery is currently exploring its role in satiety and metabolic health, including GLP-1 pathways.

© The Protein Brewery

Fermotein is made using a proprietary fungal strain that is claimed to enable low capital investment and cost-effective production. According to the company, this overcomes industry hurdles that have previously limited the affordability and scalability of alternative proteins.

The new raise follows The Protein Brewery’s €22 million Series A funding round, which took place four years ago.

“This funding is a springboard for global expansion,” said Thijs Bosch, CEO of The Protein Brewery. “With Fermotein®, we are not just offering another protein – we are redefining how food is made: nutritious, sustainable, and scalable at a lower cost. The Protein Brewery is ready to lead the protein and fiber transition. We are now entering a defining moment: all building blocks of operation are in place, and we are ready to accelerate.”

Don't miss out!

The Cultivated X newsletter:
information for decision-makers

Regularly receive the most important news from the cultivated business world.

Invalid email address

Share